CVS Health swings to $3.13 quarterly loss on $5.7 billion goodwill impairment
CVS Health reported third quarter 2025 total revenues of $102.9 billion, up 7.8%, and a GAAP diluted loss of $3.13 per share, compared with earnings of $0.07 per share a year earlier. The loss reflects a $5.7 billion goodwill impairment charge on its Health Care Delivery unit, while adjusted EPS rose to $1.60 from $1.09. The company cut its full-year GAAP EPS guidance to a loss but raised its adjusted EPS guidance, a split that shareholders will need to weigh.
Key points
- Total revenues rose to $102.9 billion from $95.4 billion, a 7.8% increase
- GAAP diluted loss of $3.13 per share included a $5.7 billion goodwill impairment; a $483 million deconsolidation gain partly offset it
- Adjusted EPS of $1.60 compared with $1.09 a year earlier, driven by the Health Care Benefits segment
- Full-year GAAP diluted EPS guidance cut to $(0.34) to $(0.24) from $3.84 to $3.94; adjusted EPS guidance raised to $6.55 to $6.65 from $6.30 to $6.40
The filing
Written by AI on Nov 8, 2026, 1:21 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 29, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.